CX3CR1 was also highly expressed in ccRCC, ranking third among solid tumors behind myeloid-rich glioblastoma multiforme (GBM) and lower-grade glioma (LGG) (Figure 8J). This evidence concerns the gene CX3CR1 and central nervous system cancer.